| ID | JOS-bpb.b13-00471 |
| 著者:名前 | |
| 著者:別形式 | Seki, Toshinobu / Hamada, Airi / Egawa, Yuya / Yamaki, Tsutomu / Uchida, Masaki / Natsume, Hideshi / Kimura, Soichiro / Ueda, Hideo |
| 著者:カナ | |
| 著者:所属 | 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 /城西大学薬学部 / 城西大学薬学部 |
| 著者:所属(別形式) | Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences /Josai University, Faculty of Pharmaceutical Sciences / Josai University, Faculty of Pharmaceutical Sciences |
| 著者版フラグ | publisher |
| 出版地 | 東京 |
| 出版者 | 日本薬学会 |
| 出版者:カナ | ニホンヤクガクカイ |
| 出版者:別名 | The Pharmaceutical Society of Japan |
| NCID | AA10885497 |
| 冊子ISSN | 09186158 |
| 電子ISSN | 13475215 |
| 掲載誌名 | |
| 巻 | 36 |
| 号 | 11 |
| 刊行年月 | 2013-11 |
| 開始ページ | 1862 |
| 終了ページ | 1866 |
| コンテンツ作成日 | 2013-08-11 |
| コンテンツ登録日 | 2014-01-29 |
| 識別番号:DOI | info:doi/10.1248/bpb.b13-00471 |
| 識別番号:DOI(リンク) | |
| 医中誌ID | 2014184071 |
| 識別番号:その他 | JOI:DN/JST.JSTAGE/bpb/b13-00471 |
| 抄録 | We applied a parallel pore permeation model based on the Renkin molecular sieving function by using two different-sized pathways to analyze the permeation-enhancing effects of poly-L-arginine (PLA) or a mixed system of spermine (SPM) and sodium taurocholate (STC). Four paracellular markers were simultaneously applied to Caco-2 cell monolayers, and a set of apparent permeability coefficient (P) values was used to obtain membrane parameters. For PLA treatment, the pore occupancy/length ratio (ε/L) of the large pathways increased while the pore radius (R) did not, suggesting that the number of large pathways for the relatively large hydrophilic molecules in the monolayers could be increased by the addition of PLA. In contrast, application of the mixed system comprising SPM and STC significantly increased not only the R of the large pathways but also ε/L of the small pathways. Such changes in membrane parameters could be related to the enhancing mechanism of these compounds. The simulation curves for molecular weight (MW)-P calculated from the membrane parameters could be used to predict the P of drugs with different MWs. |
| キーワード | |
| 言語 | eng |
| 資源タイプ | text |
| ジャンル | |
| フォーマット | application/pdf |
| 権利 | Copyright c 2013 The Pharmaceutical Society of Japan |
| このアイテムを表示する:本文(pdf) |  ( 467.1KB) ダウンロード回数: 回 |
| このアイテムを表示する:URI | |